Meta-analyses show higher GI adverse events, including biliary issues that could indirectly affect the liver, in patients with liver disease
How is Nascobal supplied NASCOBAL is a nasal spray available in a dosage strength of 500 mcg cyanocobalamin/0.1 mL (per actuation)
Collaborate with Confidence Whether you're studying metabolic pathways , evaluating drug effects, or integrating data across proteomics and metabolomics , Creative Proteomics offers the expertise and platform consistency to support your next discovery
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a doubleblind, randomised placebocontrolled trial
The most commonly prescribed GLP-1 RAs are: Semaglutide: Ozempic (type 2 diabetes), Wegovy (weight loss) Tirzepatide: Mounjaro (type 2 diabetes), Zepbound (weight loss) Dulaglutide: Trulicity (type 2 diabetes) Liraglutide: Victoza (type 2 diabetes), Saxenda (weight loss) According to the Endocrine Society, GLP-1 RAs promote early satiety, reduce food intake, and are associated with weight loss ( Endocr Pract , 2022)
Patients are usually started on a lower dose and gradually titrated up to help reduce side effects
